Adrian J. Fisher

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:  A Potent, Orally Bioavailable Human CB₁/CB₂Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration

Edward K. Dziadulewicz, Stuart Bevan, Christopher T. Brain et al. · Journal of Medicinal Chemistry · 2007 · 96 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of AZD3199, An Inhaled Ultralong Acting β₂ Receptor Agonist with Rapid Onset of Action

Michael J. Stocks, Lilian Alcaraz, Andrew Bailey et al. · ACS Medicinal Chemistry Letters · 2014 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Design driven HtL: The discovery and synthesis of new high efficacy β2-agonists

Michael J. Stocks, Lilian Alcaraz, Andrew Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists

Stephen Connolly, Lilian Alcaraz, Andrew Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Lead optimisation of pyrazoles as novel FPR1 antagonists

Andrew Morley, Sarah King, Bryan Roberts et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14